| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| interferon beta-1a 12 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| interferon beta-1a 24 MIE/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| Interferon beta-1a 30mcg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| interferon beta-1a 30 µg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| interferon beta-1a 6 MIE pulver og solvens til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| interferon beta-1a 2,4 millioner IE/ml, injektionsvæske, opløsning i fyldt injektionssprøjte a 0,2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| Peginterferon beta-1a (substance) |
Is a |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| Product containing interferon beta-1a in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 6million iu powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| Product containing only interferon beta-1a (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 24 million unit/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 24 million unit/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely interferon beta-1a 30 microgram/1 vial powder for conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 30 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 30 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Peginterferon beta-1a (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
|
| Interferon beta-1a (as peginterferon beta-1a) 250 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 44 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 44 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely interferon beta-1a 88 microgram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely interferon beta-1a 88 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 60 microgram/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
| Interferon beta-1a 60 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Interferon beta-1a (substance) |
Inferred relationship |
Some |
1 |
FHIR